{"instance_id": "ws_en_019", "response": "```markdown\n| Company Name | Listing Board | Bloomberg ticker | Listing Date | Initial Offering Price(per share) | Total Funds Raised in 2024(million) | Revenue in 2024(million) | Net Income Attributable to Shareholders(million) | R&D Expenses(million) |\n|--------------|---------------|-----------------|--------------|----------------------------------|--------------------------------------|--------------------------|-----------------------------------------------|-----------------------|\n| CG Oncology  | Nasdaq Global Select Market | CGON | 2024/01/25 | 19.00 | 380.00 | N/A | N/A | N/A |\n| Zenas BioPharma | Nasdaq Global Select Market | ZBIO | 2024/09/13 | 17.00 | 225.00 | N/A | N/A | N/A |\n| Upstream Bio | Nasdaq Global Select Market | UPB | 2024/10/11 | 17.00 | 293.00 | N/A | N/A | N/A |\n| MBX Biosciences | Nasdaq Global Select Market | MBX | 2024/09/13 | 16.00 | 163.20 | N/A | N/A | N/A |\n| Metagenomi | Nasdaq Global Select Market | MGX | 2024/02/09 | 16.00 | 93.75 | N/A | N/A | N/A |\n```"}
